Published in Curr Stem Cell Res Ther on March 01, 2013
The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br Med Bull (2013) 1.04
Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med (2013) 0.97
Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis. Stem Cells Int (2015) 0.81
Amniotic fluid derived stem cells give rise to neuron-like cells without a further differentiation potential into retina-like cells. Am J Stem Cells (2013) 0.78
SOX9 as a Predictor for Neurogenesis Potentiality of Amniotic Fluid Stem Cells. Stem Cells Transl Med (2014) 0.76
Senescence-Associated Molecular and Epigenetic Alterations in Mesenchymal Stem Cell Cultures from Amniotic Fluid of Normal and Fetus-Affected Pregnancy. Stem Cells Int (2016) 0.75
Osteogenic Differentiation of Human Amniotic Fluid Mesenchymal Stem Cells Is Determined by Epigenetic Changes. Stem Cells Int (2016) 0.75
Counteracting bone fragility with human amniotic mesenchymal stem cells. Sci Rep (2016) 0.75
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res (2004) 2.24
HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat (2007) 2.22
Disuniting uniformity: a pied cladistic canvas of mtDNA haplogroup H in Eurasia. Mol Biol Evol (2004) 1.74
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev (2007) 1.36
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. Blood (2010) 1.21
Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol Cell Proteomics (2011) 1.14
Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med (2009) 1.07
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Human microRNA target analysis and gene ontology clustering by GOmir, a novel stand-alone application. BMC Bioinformatics (2009) 1.00
Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status. Gynecol Oncol (2005) 0.99
Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med (2013) 0.97
Persistent gamma-globin expression in adult transgenic mice is mediated by HPFH-2, HPFH-3, and HPFH-6 breakpoint sequences. Blood (2003) 0.96
Stem cells: insights into the secretome. Biochim Biophys Acta (2013) 0.95
Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int (2012) 0.94
Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol (2010) 0.94
OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Mol Carcinog (2011) 0.93
In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med (2011) 0.93
Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization. PLoS One (2013) 0.92
Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation. Virus Res (2013) 0.92
Major challenges for gene therapy of thalassemia and sickle cell disease. Curr Gene Ther (2010) 0.90
Analysis of secreted proteins for the study of bladder cancer cell aggressiveness. J Proteome Res (2010) 0.89
Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. World J Gastroenterol (2005) 0.88
A novel function for the haemopoietic supportive murine bone marrow MS-5 mesenchymal stromal cell line in promoting human vasculogenesis and angiogenesis. Br J Haematol (2012) 0.86
Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease. Inflamm Bowel Dis (2008) 0.86
Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer. Stem Cells Dev (2011) 0.86
5-HT2A receptor gene polymorphisms and irritable bowel syndrome. J Clin Gastroenterol (2011) 0.85
Serum protein profile of Crohn's disease treated with infliximab. J Crohns Colitis (2013) 0.84
Persistent fetal gamma-globin expression in adult transgenic mice following deletion of two silencer elements located 3' to the human Agamma-globin gene. Mol Med (2009) 0.84
An embryonic-specific repressor element located 3' to the Agamma-globin gene influences transcription of the human beta-globin locus in transgenic mice. Exp Hematol (2004) 0.83
Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer. Proteomics (2009) 0.83
NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease. World J Gastroenterol (2010) 0.83
The major circadian pacemaker ARNT-like protein-1 (BMAL1) is associated with susceptibility to gestational diabetes mellitus. Diabetes Res Clin Pract (2012) 0.82
Gestational diabetes exhibits lack of carnitine deficiency despite relatively low carnitine levels and alterations in ketogenesis. J Matern Fetal Neonatal Med (2005) 0.81
Stem cells as potential targeted therapy for inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.81
Platelet-rich plasma (PRP) promotes fetal mesenchymal stem/stromal cell migration and wound healing process. Stem Cell Rev (2014) 0.81
Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology. Evol Bioinform Online (2013) 0.81
Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection. World J Gastroenterol (2012) 0.81
The new self-inactivating lentiviral vector for thalassemia gene therapy combining two HPFH activating elements corrects human thalassemic hematopoietic stem cells. Hum Gene Ther (2011) 0.80
The hematopoietic chemokine CXCL12 promotes integration of human endothelial colony forming cell-derived cells into immature vessel networks. Stem Cells Dev (2014) 0.80
Expression profiling of vulvar carcinoma: clues for deranged extracellular matrix remodeling and effects on multiple signaling pathways combined with discrete patient subsets. Transl Oncol (2011) 0.80
Circadian clock gene expression is impaired in gestational diabetes mellitus. Gynecol Endocrinol (2013) 0.79
Emerging issues of the expression profiling technologies for the study of gynecologic cancer. Am J Obstet Gynecol (2005) 0.78
Functional role of the four different types of (AT)(x)T(y) motifs 5' to the beta-globin gene and their distribution in the Greek population. Blood Cells Mol Dis (2002) 0.78
Transcription factor ATF-3 regulates allele variation phenotypes of the human SLC11A1 gene. Mol Biol Rep (2012) 0.77
Compounds of the anthracycline family of antibiotics elevate human gamma-globin expression both in erythroid cultures and in a transgenic mouse model. Blood Cells Mol Dis (2009) 0.77
Fetal mesenchymal stem cells in cancer therapy. Curr Stem Cell Res Ther (2013) 0.77
Therapeutic potential of fetal mesenchymal stem cells. Curr Stem Cell Res Ther (2013) 0.77
Polymorphism Analysis of VSX1 and SOD1 Genes in Greek Patients with Keratoconus. Ophthalmic Genet (2015) 0.76
Dynamic retrotransposition of ERV-9 LTR and L1 in the beta-globin gene locus during primate evolution. Mol Phylogenet Evol (2004) 0.76
Gene fusion analysis in the battle against the African endemic sleeping sickness. PLoS One (2013) 0.75
The Ongoing Challenge of Hematopoietic Stem Cell-Based Gene Therapy for β-Thalassemia. Stem Cells Int (2011) 0.75
Variable effects of maternal and paternal-fetal contribution to the risk for preeclampsia combining GSTP1, eNOS, and LPL gene polymorphisms. J Matern Fetal Neonatal Med (2010) 0.75
Maternal and fetal circulating sKL and ET-1 levels as function of normal labor at term. J Matern Fetal Neonatal Med (2010) 0.75
Low serum gamma-glutamyltranspeptidase (GGT) in patients with chronic idiopathic neutropenia is not implicated in the pathophysiology of the disease. Haematologica (2003) 0.75